Annual EBIT
-$98.55 M
+$12.47 M+11.24%
December 1, 2023
Summary
- As of February 23, 2025, MAZE annual earnings before interest & taxes is -$98.55 million, with the most recent change of +$12.47 million (+11.24%) on December 1, 2023.
- During the last 3 years, MAZE annual EBIT has risen by +$12.47 million (+11.24%).
Performance
MAZE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$24.23 M
NaN%
September 1, 2024
Summary
- As of February 23, 2025, MAZE quarterly earnings before interest & taxes is -$24.23 million
- Over the past year, MAZE quarterly EBIT has stayed the same.
Performance
MAZE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$47.28 M
NaN%
September 1, 2024
Summary
- As of February 23, 2025, MAZE TTM earnings before interest & taxes is -$47.28 million
- Over the past year, MAZE TTM EBIT has stayed the same.
Performance
MAZE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MAZE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.2% | 0.0% | 0.0% |
| 3 y3 years | +11.2% | 0.0% | 0.0% |
| 5 y5 years | +11.2% | 0.0% | 0.0% |
MAZE EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +12.7% | +5.1% | +4.1% | +87.4% | +2.1% |
| 5 y | 5-year | at high | +12.7% | +5.1% | +4.1% | +87.4% | +2.1% |
| alltime | all time | at high | +12.7% | +5.1% | +4.1% | +87.4% | +2.1% |
Maze Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$24.23 M(+5.1%) | -$47.28 M(-2.1%) |
| Dec 2023 | -$98.55 M | -$23.05 M(-8.6%) | -$48.28 M(+91.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$25.23 M | -$25.23 M |
| Dec 2022 | -$111.03 M | - | - |
FAQ
- What is Maze Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Maze Therapeutics?
- What is Maze Therapeutics annual EBIT year-on-year change?
- What is Maze Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Maze Therapeutics?
- What is Maze Therapeutics quarterly EBIT year-on-year change?
- What is Maze Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Maze Therapeutics?
- What is Maze Therapeutics TTM EBIT year-on-year change?
What is Maze Therapeutics annual earnings before interest & taxes?
The current annual EBIT of MAZE is -$98.55 M
What is the all time high annual EBIT for Maze Therapeutics?
Maze Therapeutics all-time high annual earnings before interest & taxes is -$98.55 M
What is Maze Therapeutics annual EBIT year-on-year change?
Over the past year, MAZE annual earnings before interest & taxes has changed by +$12.47 M (+11.24%)
What is Maze Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of MAZE is -$24.23 M
What is the all time high quarterly EBIT for Maze Therapeutics?
Maze Therapeutics all-time high quarterly earnings before interest & taxes is -$23.05 M
What is Maze Therapeutics quarterly EBIT year-on-year change?
Over the past year, MAZE quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Maze Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of MAZE is -$47.28 M
What is the all time high TTM EBIT for Maze Therapeutics?
Maze Therapeutics all-time high TTM earnings before interest & taxes is -$25.23 M
What is Maze Therapeutics TTM EBIT year-on-year change?
Over the past year, MAZE TTM earnings before interest & taxes has changed by $0.00 (0.00%)